ARCHIVES

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

This article is from The Cancer Letter archive.

Vol. 24 No. 16 | April 24, 1998

Download PDF Visit The Full Archive

Related Articles

NSABP’s Pink Sheet; Fisher’s Control Had A Downside, Review Said

June 24, 1994

Simons Named CEO of Prostate Cancer Foundation.

November 17, 2006

NCI’s Otis Brawley Named Professor At Emory, Associate Director, Cancer Control, At Winship.

April 20, 2001

Institute of Medicine Elects 70 Members at Annual Meeting

October 25, 2013

AIDS Patients Face Higher Risk Of HPV-Related Cancers As Immunosuppression Grows

August 28, 2009

Challoner: We Recommended FDA Replace 510(k) Clearance

July 4, 2014